Kun Chin Liu

Title: Kun Chin Liu: Innovator in Pharmaceutical Compounds

Introduction

Kun Chin Liu is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific diseases. With a total of 2 patents, his work is recognized for its potential impact on medical treatments.

Latest Patents

Liu's latest patents include innovative compounds aimed at treating various medical conditions. One of his notable inventions is related to quinoline compounds and compositions for inhibiting EZH2. This invention focuses on aza-quinoline compounds of Formula (I), which are used in pharmaceutical compositions for treating diseases mediated by Enhancer of Zeste Homolog (EZH) and Polycomb Repressive Complex (PRC). Another significant patent involves MLL1 inhibitors and anti-cancer agents. This invention provides a compound of Formula (I) and outlines methods for using these compounds to treat conditions mediated by mixed lineage leukemia 1 (MLL1).

Career Highlights

Throughout his career, Kun Chin Liu has worked with esteemed organizations such as China Novartis Institutes for Biomedical Research Co., Ltd. and Novartis AG. His experience in these companies has allowed him to contribute to groundbreaking research and development in the pharmaceutical industry.

Collaborations

Liu has collaborated with notable colleagues, including Zhenting Gao and Haibing Guo. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Kun Chin Liu's contributions to pharmaceutical innovations demonstrate his commitment to advancing medical science. His patents reflect a deep understanding of complex biological mechanisms and a dedication to improving patient outcomes.